FDA Approval Activities for this Drug…

Desferal (deferoxamine mesylate, USP) Injection, Novartis Pharmaceutical Company NDA 16-267/S-039 2/14/02 3/8/02 Desferal (deferoxamine mesylate, USP) Injection, Novartis Pharmaceutical Company NDA 16-267/S-034 Deferoxamine Mesylate Injection, Abbott Laboratories

For the latest approval information, please locate this drug using this index.